BioTek Instruments, MilliporeSigma collaborate on integrated solution for long-term live cell experiments

NewsGuard 100/100 Score

BioTek Instruments is pleased to announce its collaboration with MilliporeSigma on an integrated solution for long-term live cell experiments and dynamic time-lapse analyses, including automated cell perfusion and imaging. The solution leverages each company’s respective expertise, and consists of BioTek’s new Lionheart™ FX Automated Live Cell Imager and MilliporeSigma’s new CellASIC® ONIX2 Microfluidic System.

This collaborative solution was introduced at the American Association of Cancer Research (AACR) Annual Meeting recently held April 16-20, 2016 in New Orleans, LA.

The Lionheart FX Automated Live Cell Imager is optimized for live cell microscopy, with up to 100x magnification and brightfield, color brightfield, phase contrast and fluorescence channels. Gen5™ 3.0 Software powers Lionheart FX, and allows quick and effortless cell image capture, analysis, annotation and time lapse video production.

The CellASIC® ONIX2 Microfluidic System automates dynamic environmental control over live cells, with high precision controls, expansive functionality and user-friendly operation. Its unique microfluidics technology provides hands-free control over drug addition, gas, temperature, media and more, along with customizable media flow rates.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research unveils bispecific antibodies for B-cell lymphoma treatment